Lido Advisors, LLC Mustang Bio, Inc. Transaction History

Lido Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.66 - $2.64 $16,600 - $26,400	-10,000 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$3.02 - $5.16 $30,200 - $51,600	-10,000 Reduced 50.0%	10,000 $33,000
Q4 2020 Feb 08, 2021	SELL	$2.66 - $4.18 $34,580 - $54,339	-13,000 Reduced 39.39%	20,000 $75,000
Q1 2020 May 13, 2020	BUY	$1.91 - $4.52 $63,030 - $149,160	33,000 New	33,000 $88,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $21M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.